These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23302021)

  • 1. A French national survey on the use of antibiotic prophylaxis in cirrhotic patients.
    Thevenot T; Degand T; Grelat N; Elkrief L; Christol C; Moreau R; Henrion J; Cadranel JF; Sheppard F; Bureau C; di Martino V; Pauwels A;
    Liver Int; 2013 Mar; 33(3):389-97. PubMed ID: 23302021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.
    Fernández J; Ruiz del Arbol L; Gómez C; Durandez R; Serradilla R; Guarner C; Planas R; Arroyo V; Navasa M
    Gastroenterology; 2006 Oct; 131(4):1049-56; quiz 1285. PubMed ID: 17030175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bacterial infections in liver cirrhosis].
    Papp M; Farkas A; Udvardy M; Tornai I
    Orv Hetil; 2007 Mar; 148(9):387-95. PubMed ID: 17344166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis.
    Bernard B; Grangé JD; Khac EN; Amiot X; Opolon P; Poynard T
    Hepatology; 1999 Jun; 29(6):1655-61. PubMed ID: 10347104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic prophylaxis for prevention of spontaneous bacterial peritonitis in patients without gastrointestinal bleeding.
    Segarra-Newnham M; Henneman A
    Ann Pharmacother; 2010 Dec; 44(12):1946-54. PubMed ID: 21098755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.
    Sàbat M; Kolle L; Soriano G; Ortiz J; Pamplona J; Novella MT; Villanueva C; Sainz S; Torras J; Balanzó J; Guarner C
    Am J Gastroenterol; 1998 Dec; 93(12):2457-62. PubMed ID: 9860409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Spontaneous bacterial peritonitis].
    Velkey B; Vitális E; Vitális Z
    Orv Hetil; 2017 Jan; 158(2):50-57. PubMed ID: 28088889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection.
    Pauwels A; Mostefa-Kara N; Debenes B; Degoutte E; Lévy VG
    Hepatology; 1996 Oct; 24(4):802-6. PubMed ID: 8855179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic prophylaxis in urology departments, 2005-2010.
    Çek M; Tandoğdu Z; Naber K; Tenke P; Wagenlehner F; van Oostrum E; Kristensen B; Bjerklund Johansen TE;
    Eur Urol; 2013 Feb; 63(2):386-94. PubMed ID: 23031676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibiotic prophylaxis in liver cirrhosis].
    Restellini S; Nendaz M; Morard I
    Rev Med Suisse; 2012 Feb; 8(326):276, 278-81. PubMed ID: 22364077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of probiotics to norfloxacin does not improve efficacy in the prevention of spontaneous bacterial peritonitis: a double-blind placebo-controlled randomized-controlled trial.
    Pande C; Kumar A; Sarin SK
    Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):831-9. PubMed ID: 22522141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guideline adherence and outcomes in esophageal variceal hemorrhage: comparison of tertiary care and non-tertiary care settings.
    Schlansky B; Lee B; Hartwell L; Urquhart J; Willis B; Zaman A
    J Clin Gastroenterol; 2012 Mar; 46(3):235-42. PubMed ID: 21778893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients.
    Ortiz J; Vila MC; Soriano G; Miñana J; Gana J; Mirelis B; Novella MT; Coll S; Sábat M; Andreu M; Prats G; Solá R; Guarner C
    Hepatology; 1999 Apr; 29(4):1064-9. PubMed ID: 10094947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial infections in liver disease.
    Navasa M; Rimola A; Rodés J
    Semin Liver Dis; 1997; 17(4):323-33. PubMed ID: 9408968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous bacterial peritonitis recurrence in patients with cirrhosis receiving secondary prophylaxis with norfloxacin.
    Marciano S; Dirchwolf M; Diaz JM; Bermudez C; Gutierrez-Acevedo MN; Barcán LA; Smud A; Giunta D; Gadano AC
    Eur J Gastroenterol Hepatol; 2019 Apr; 31(4):540-546. PubMed ID: 30557229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous bacterial peritonitis: a therapeutic update.
    Strauss E; Caly WR
    Expert Rev Anti Infect Ther; 2006 Apr; 4(2):249-60. PubMed ID: 16597206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cost analysis of long term antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhosis.
    Das A
    Am J Gastroenterol; 1998 Oct; 93(10):1895-900. PubMed ID: 9772051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled study of trimethoprim-sulfamethoxazole versus norfloxacin for the prevention of infection in cirrhotic patients.
    Lontos S; Shelton E; Angus PW; Vaughan R; Roberts SK; Gordon A; Gow PJ
    J Dig Dis; 2014 May; 15(5):260-7. PubMed ID: 24612987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 4% gelofusine plus antibiotics on renal impairment and mortality in high-risk cirrhotic patients with spontaneous bacterial peritonitis.
    Sirinthornpunya S; Luangvichcharoen K
    J Med Assoc Thai; 2013 Mar; 96 Suppl 3():S77-83. PubMed ID: 23682527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic prophylaxis practices in dentistry: a survey of dentists and physicians.
    Lauber C; Lalh SS; Grace M; Smith MH; MacDougall K; West P; Compton S
    J Can Dent Assoc; 2007 Apr; 73(3):245. PubMed ID: 17439709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.